TORONTO, Jan. 29, 2026 (GLOBE NEWSWIRE) -- NetraMark Holdings Inc. (the “Company” or “NetraMark”) (CSE: AIAI) (OTCQB: AINMF) (Frankfurt: PF0), a premier artificial intelligence (AI) company transforming clinical trials with AI-powered precision analytics in the pharmaceutical industry, today announced that Lawrence Guy is joining the Company’s Board of Directors (“the Board”). Mr. Guy’s appointment further strengthens the Board with his deep experience in capital markets, investment management, and public-c ...

TORONTO, Jan. 28, 2026 (GLOBE NEWSWIRE) -- NetraMark Holdings Inc. (the “Company” or “NetraMark”) (CSE: AIAI) (OTCQB: AINMF) (Frankfurt: PF0), a premier artificial intelligence (AI) company transforming clinical trials with AI-powered precision analytics in the pharmaceutical industry, today announced that further to its press release on January 13, 2026, it has closed the first tranche of its previously announced non-brokered private placement for gross proceeds of $3,110,000 (the “First Tranche”). Under t ...

As Filed with the Securities and Exchange Commission on January 26, 2026. UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 AIAI HOLDINGS CORPORATION (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation or organization) (Primary Standard Industrial Classification Code Number) 33-4103471 (I.R.S. Employer Identification Number) 17304 Preston Road, Suite 520 Dallas, TX ...